In other countries
The same active substances on other registers, the same brand first.
- Anticoagulant Citrate Dextrose Solution USP (Acd) Formula ACanada · 730 MG / 100 ML + 2.45 G / 100 ML + 2.2 G / 100 ML · Solution · Fresenius Kabi AGSame substance
- Anticoagulant Citrate Dextrose Solution USP (Acd) Formula ACanada · 770 MG / 100 ML + 2.54 G / 100 ML + 2.14 G / 100 ML · Solution · Fresenius Kabi AGSame substance
- A-C-D SolutionCanada · 80 MG / 10 ML + 132 MG / 10 ML + 250 MG / 10 ML · Liquid · Draximage A Division of Draxis Specialty Pharmaceuticals INCSame substance
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
PHARMAC, New Zealand
New Zealand Pharmaceutical Management Agency (PHARMAC); https://schedule.pharmac.govt.nz/pub/HML/archive/2026/2026-10-01/HML_2026-10-01.xml; October 2026; published 2026-10-01; acquired 2026-10-13T22:49:54.923639+00:00. XML-to-graph and conservative medicine-domain projections are adaptations. Written attribution; PHARMAC logo excluded.
Licence: CC BY 4.0; PHARMAC Pharmaceutical Schedule XML files · Added 14 Oct 2026